ArticleEMBO molecular medicine2014

Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype.

Marta Larrayoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.